Cargando…
Corticosteroid Therapy in Management of Myocarditis Associated with COVID-19; a Systematic Review of Current Evidence
INTRODUCTION: Myocarditis in patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seems to be associated with a higher mortality rate. This study aims to summarize the latest evidence on whether the use of corticosteroids in patients with myocarditis associated with CO...
Autores principales: | Kamarullah, William, Nurcahyani, Mary Josephine, Claudia, Bill Multazam, Rachmatu, Ghaezany Nawing, Aqila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shahid Beheshti University of Medical Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126353/ https://www.ncbi.nlm.nih.gov/pubmed/34027427 http://dx.doi.org/10.22037/aaem.v9i1.1153 |
Ejemplares similares
-
Durvalumab-associated Late-onset Myocarditis Successfully Treated with Corticosteroid Therapy
por: Maetani, Tomoki, et al.
Publicado: (2021) -
Myocarditis and inflammatory cardiomyopathy: current evidence and future directions
por: Tschöpe, Carsten, et al.
Publicado: (2020) -
COVID-19 Vaccines and Myocarditis: An Overview of Current Evidence
por: Hromić-Jahjefendić, Altijana, et al.
Publicado: (2023) -
Corticosteroids and Intravenous Immunoglobulin in Pediatric Myocarditis: A Meta-Analysis
por: Li, Yining, et al.
Publicado: (2019) -
Corticosteroid in anti-inflammatory treatment of pediatric acute myocarditis: a systematic review and meta-analysis
por: Yao, Qi, et al.
Publicado: (2023)